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doi:10.1016/j.jfma.2012.02.001Background/Purpose: To investigate the clinical features and visual outcomes of acute optic
neuritis in adult patients.
Methods: We prospectively collected ninety-nine adult patients, who were found to have
acute optic neuritis between 2005 and 2007 at National Taiwan University Hospital. A total
of 30 cases, aged ranging from 21 to 55 years old (average 36.4  9.9), that followed up at least
6 months were enrolled in our study. Baseline clinical features and visual function results were
analyzed.
Results: The mean follow-up period was 15.6 months. Twenty three (76.7%) cases were
female. Twenty-seven cases were unilateral involved, one was simultaneously bilateral
involved and two was sequentially bilateral involved. In total 33 affected eyes, ocular or perio-
cular pain was noted in 14 eyes (69.7%). Optic disc swelling was noted in 5 eyes (15.2%). A total
of 6 cases had recurrent episodes, and two of them were diagnosed with multiple sclerosis
thereafter. At 6-month follow up, 24 eyes (72.7%) had good visual recovery (better than 20/
40). Only 2 eyes (6%) had severe visual loss (<20/1000). Optic disc pale was detected in
72.7% of the eyes during follow up.
Conclusion: Visual recovery was observed in most eyes with acute optic neuritis, although disc
pale detectable. Patients with recurrent optic neuritis had worse visual outcome. There was
a low association of optic neuritis with multiple sclerosis in our patients.
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Figure 1 Distribution of corrected visual acuity of affected
eyes at disease onset and 6-month follow-up.
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Optic neuritis (ON) is an inflammation of the optic nerve
that usually affects young people ranging from 18e45 years
of age, who eventually experience good visual recovery. ON
can be a monophasic or polyphasic disease isolated to the
optic nerve(s) or can be associated with a more widespread
demyelinating disorder of the central nervous system such
as multiple sclerosis (MS) or neuromyelitis optica (NMO).1
In Western countries, natural history and treatment of
ON and its relation to MS have been studied extensively.1
Intravenous methylprednisolone may accelerate visual
recovery in ON; however, it has no effect on long-term
visual outcome.2,3 Most patients may retain good to
excellent vision more than 10 years after an initial episode
of ON.3 But the long-term rate of conversion of ON to MS
is high, ranging from 38% to 75%.1The presence of white
matter lesions on the initial magnetic resonance image
(MRI) of the brain has been identified as the strongest
predictor for the development of MS.4 Recent efforts have
been made to identify the patients at high risk of MS and
begin a disease-modifying drug at the time of a clinically
isolated demyelinating syndrome such as ON to reduce the
rate of development of MS.1
In Asian countries, MS is known to present differently
than in Western countries. It is characterized by the
selective and severe involvement of the optic nerve and
spinal cord as well as low prevalence rates.5 It is not clear
whether the natural history of ON occurring in Asians is, like
that of MS, different from that of Western populations. In
hospital-based case series, some racial differences were
found in the characteristics of the disease.6,7 Moreover, the
conversion rate of ON to MS in the Asian population was
low.7,8
It is important to understand the clinical features of ON
and their relation to MS in Asian patients. We prospectively
followed up adult patients with acute ON, and its baseline
clinical features at onset and visual outcomes were analyzed.
Patients and methods
From May 2005 to December 2007, we conducted a prospec-
tive clinical study to follow up the adult patients with acute
ON at National Taiwan University Hospital. Inclusion criteria
included patients older than 18 years with the clinical
diagnosis of a first episode of unilateral or bilateral ON and
willingness to sign informed consent for study and follow-
up. The diagnosis of ON was defined according to the clin-
ical criteria of Perkin and Rose9 as “a condition causing
a relatively rapid onset of visual failure, in which no
evidence for a toxic, vascular, or compressive etiology can
be discovered, and where local retinal lesions have been
excluded” with clinical and radiographic examinations to
rule out other causes of vision loss. The severity of visual
acuity loss can be variable, but visual field defect, color
vision impairment, and an ipsilateral afferent pupillary
defect should be detected. Patients with a history of MS or
any systemic disease that would make them unsuitable for
long-term follow-up were also excluded. Institutional
review board approval by the Ethics Committee of National
Taiwan University Hospital was obtained.Ninety-nine patients (potential study patients) in whom
ON was diagnosed were identified. However, only 34
patients wanted to participate in long-term follow-up for at
least 6 months; during this period, no further medication
will be given. Among these patients, four were excluded
because one was suspected of having anterior ischemic
optic neuropathy, one was suspected of having orbital
inflammation, one had a past history of recurrent ON, and
one had unexplained bilateral loss of vision. Thus, a total of
30 adult patients with ON were enrolled in our study. These
patients had received pulse therapy with intravenous
methylprednisolone 250 mg every 6 hours for 3 days
consecutively, followed by oral prednisolone for 1 to 2
weeks, to treat acute ON according to the protocol of the
Optic Neuritis Treatment Trial2 (ONTT). Recurrent attacks
were defined as second ON episodes occurring more than 1
month later. Demographic data and baseline clinical
features were recorded. Visual functions including visual
acuity, color vision, and visual field were followed at acute
onset and 6-month follow-up visit. Best corrected visual
acuity (BCVA) was measured to full refractive correction
using the Landolt C chart at a viewing distance of 5 meters,
and the results of decimal acuity were calculated as the
logarithm of the minimal angle of resolution (logMAR).
Color vision was tested using pseudoisochromatic Ishihara
plates (a total of 14 plates). Numbers of correctly recog-
nized plates give a score of 0 to 14, with 14 considered
normal color vision. Visual field was assessed using the
Humphrey Field Analyzer (program 30-2) (Zeiss-Humphrey
System, Dublin, CA, USA). Field loss severity was defined as:
severe (mean deviation greater than -20.0 dB), moderate
(mean deviation greater than -6.0 dB but less than
-20.0 dB), and minimal (mean deviation greater than
-3.0 dB but less than -6.0 dB).
The clinical features of the eyes that had visual acuity
worse than 20/40 at 6 months were compared with that of
the eyes that had visual acuity of 20/40 or better at 6
months, using the Fisher exact test.
Results
A total of 30 adult patients with ON were included in this
study, ranging in age from 21 to 55 years (average
36.4  9.9 years). The mean follow-up period was 15.6
months. There were 23 female and seven male patients
(female, 76.7%). Twenty-nine patients were Chinese and
one was a Vietnamese woman. During the follow-up period,
Figure 2 Visual acuity (mean of logarithm of the minimal
angle of resolution, logMAR) during follow-up.
Figure 3 Color vision of the affected eyes at disease onset
and 6-month follow-up.
Visual function in acute optic neuritis patients 89six patients had recurrent ON (three in the same eye, two in
the other eye, and one with relapse in one eye of the
previously bilateral ON). Thus, a total of 30 patients (33
affected eyes), including 27 patients with unilateral ON,
one with bilateral simultaneous ON, and two with bilateral
sequential ON, were included in this study.
Ocular or periocular pain was noted in 14 eyes (69.7% of
the affected eyes). Optic disc swelling was seen in five eyes
(15.2% of the affected eyes). Six patients had recurrent
episodes, all of them had retrobulbar type ON, and two of
them had MS (one with opticospinal MS) 4 months after the
onset of ON.
Visual acuity was measured in all 33 affected eyes. Fig. 1
showed the distribution of BCVA in the affected eyes during
the disease onset and after 6-month follow-up. During
disease onset, decrease in visual acuity was variable, but
most patients had moderate to severe visual loss. Among 12
affected eyes with severe vision loss (< 20/1000) initially,
nine had recovered visual acuity better than 20/40. At
6-month follow up, 24 eyes (72.7%) had good visual
recovery (better than 20/40). Only two eyes (6%) had
severe vision loss (< 20/1000). Patients who had longer
follow-up showed stabilized vision after 6-month follow-up
(Fig. 2). When considering factors affecting the visual
outcome, recurrent ON was calculated to be statisticallyTable 1 Comparison of clinical features of affected eyes
with poor visual recovery to eyes with good visual recovery.
Visual acuity at 6 months pa
VA < 20/40 VA 20/40
or better
Optic disc
Normal 8 20 0.582
Swollen 1 4
Baseline VA
<20/1000 4 8 0.261
20/1000 or better 5 16
ON episode
Single 4 20 0.039
Recurrent 5 4
VA Z visual acuity.
a Fisher exact test.significant (Table 1). Although at least two thirds of the
affected eyes had visual recovery better than 20/40, a pale
disc was detected in 72.7% of the eyes during follow-up.
Color vision impairment was found in most of the
affected eyes during disease onset, with 63.6% recognizing
fewer than three plates during disease onset. In addition,
63.6% of the affected eyes had good recovery after 6-month
follow-up (Fig. 3).
Field loss pattern was presented with great variety. The
most common type of visual field defect was diffuse
depression (39.4%) and the most common type of focal field
defect was altitudinal field defect at disease onset
(Table 2). Most eyes had severe to moderate field loss
initially (Fig. 4). In addition, 66.7% of the affected eyes had
only minimal field loss or normal visual field at 6-month
follow-up. Further visual field follow-up was available for
8 patients at 1 year, and 6 patients for more than 18
months. It showed that the visual field change was quite
stable compared with 6-month data.
In two cases, demyelinating disease was diagnosed
during the follow-up period. Case 1 was a 36-year-old male
with recurrent retrobulbar ON. Opticospinal MS (OS-MS) was
diagnosed 4 months after the first onset of ON. His vision
declined to 20/200 and did not recover until the second
episode of ON in the same eye. Case 2 was a 21-year-old
female with recurrent retrobulbar ON. MS was diagnosed at
4 months after the first onset. Multiple relapses of ON
occurred during follow-up, with two episodes in the same
eye and one episode in the other eye. In each episode, she
had severe visual loss in the affected eye. However, sheTable 2 Type of visual field abnormality.
Type of abnormality At onset
(no. of eyes)
At 6 months
(no. of eyes)
Diffuse depression 13 3
Cecocentral 3 4
Altitudinal 9 5
Peripheral rim 2 1
Arcuate 2 3
Central 2 3
Temporal hemianopia 1 0
Three quadrantic 1 1
Scattered 0 1
Normal 0 12
Figure 4 Visual field loss of the affected eyes at disease
onset and 6-month follow-up.
90 I-H. Wang et al.recovered good central visual acuity in both eyes, even
though residual field defect and pale disc were present.
Discussion
We prospectively studied the adult patients with a first
episode of acute ON. The clinical features were compared
with previous retrospective studies in Taiwan and summa-
rized in Table 3. In our study, the mean age of onset was
36.4 years and 76.7% of the patients were female. The age
of onset was similar to that in most of the Taiwan studies
except for the report by Lin et al,7 which collected patients
with wider ranges in age. Compared with reports from
Japan and the ONTT (Table 4), patients in the Japan study
had similar age of onset; in contrast, the age of onset was
younger in patients in the ONTT. The percentage of female
patients was lowest in the study by Lin et al7 and higher in
the ONTT and our study.
The incidence of bilateral ON was lower in our study in
comparison with the Taiwan studies. Adult-onset ON isTable 3 Comparison of clinical features and visual outcome of
Retrospective case series Bee et al13 Lin et al7
Follow-up period
Range
(mean)
1992-2001
14 mo-9 y
(4.3 y)
1986-2003
1-16.8 y
(5.2 y)
Case number 27 109
Sex, female% 66.7% 53.2%
Age range, y, (mean) 13-54 (35.8) 7-80 (41.2)
Unilateral: bilateral 22:5 71:38
Disc swelling 44.4% 53.2%
Ocular pain 44.4% 56.3%
Presenting VA (mean of logMAR) Unilateral: 1.03
Bilateral: 1.60
non-MS: 1.
MS: 1.4
Presenting VF
(most common pattern)
Diffuse
depression: 47.8%
aCentral or
scotoma: 4
Outcome VA (mean of logMAR) Unilateral: 0.39
Bilateral: 1.28
With pulse
No pulse st
Outcome VA better than 20/40 Unilateral: 63.6%
Bilateral: nil
NA
Recurrent ON 18.5% 33.95%
MS conversion during follow-up 14.8% 2-yr: 5.92%
5-yr: 14.28
logMAR Z logarithm of the minimal angle of resolution; ON Z optic
a In Lin’s series, field defect was classified as normal, central, or ptypically unilateral. Simultaneous bilateral acute ON has
been considered rare, particularly in individuals without
known systemic inflammatory or autoimmune disease.
However, recurrent ON can occur in either eye. In our
study, short follow-up time may give the result of lower
incidence of bilateral involvement.
Ocular pain was reported in approximately 44-64% of the
patients in the Taiwan studies, which was similar to findings
in the Japan study. These findings differed from those in
the ONTT; 92% of their patients had ocular pain.
Surprisingly, only 15.2% of patients in our series had disc
swelling, which was lower than the ONTT findings (35%),
and much lower than other reports (44-55%). This may be
due to the early detection of ON, or because most of our
cases were of the retrobulbar type. Disc swelling was not
a factor in predicting the visual outcome in the ONTT10 and
our study (Table 1). However, disc swelling was associated
with a lower risk of MS in the ONTT.4
In our study, most of the affected eyes had color vision
impairment during disease onset. In addition, 63.6% of the
affected eyes had good recovery. In the ONTT, almost all
patients with decreased visual acuity also had abnormal
color vision at disease onset. Even in patients with visual
acuity of 20/20 or better, abnormal color plate testing was
seen in 51.1% of the patients.11
The presenting vision of ON was variable in all studies
(Tables 3 and 4). The presenting field defect was also
variable and the most common type was diffuse depression;
this finding was similar in all of the studies (Tables 3 and 4).
Local field defect was also present with great variety. In our
study, nine patients showed altitudinal field defect;
however, altitudinal field defect was not a feature specific
to ischemic optic neuropathy.ON in studies of Taiwan.
Chang et al12 Our study
(prospective)
1991-2000
Retrobulbar group: 59 mo
Papillitis group: 63.8 mo
2005-2007
6 mo-2 y
(15.6 mo)
43 30
65.1% 76.7%
18-60 (34.8) 21-55 (36.4)
30:13 27:3
55.8% 15.2%
64.3% 69.7%
3 1.47 1.18
paracentral
2.2%
Diffuse
depression: 44%
Diffuse
depression: 39.4%
steroid: 0.59
eroid: 0.58
Retrobulbar group: 0.51
Papillitis group: 0.32
0.29
NA 72.7% at 6 mo
37.2% 20%
%
18.6% 6.7%
neuritis; VA Z visual acuity; VF Z visual field.
aracentral scotoma, or nonspecific findings.
Table 4 Comparison of clinical features of ON in studies of Japan and ONTT.
Case series Wakakura et al6 ONTT11 Our study
Case number 70 448 30
Sex, female% 69% 77.2% 76.7%
Age range, y (mean) 14-55 (36.3) 18-46 (31.8) 21-55 (36.4)
Disc swelling 50% 35.3% 15.2%
Ocular pain 56% 92.2% 69.7%
Presenting VA
>20/40 10% 35.3% 15.2%
20/200-20/40 28.6% 28.8% 30.3%
20/2000-20/200 44.3% 20.3% 24.2%
<20/2000 17.1% 15.6% 30.3%
Presenting VF (most common pattern) Diffuse depression: 37.5% Diffuse depression: 44.8% Diffuse depression: 39.4%
VA Z visual acuity; VF Z visual field.
Visual function in acute optic neuritis patients 91Visual recovery was prompt in most patients (visual
acuity better than 20/40 in 72.7% at 6-month follow-up) in
our study, and better than the retrospective study in
Taiwan (Table 3). This discrepancy may be because that
retrospective study tended to include more long-term
follow-up patients with worse visual outcome, and loss of
good visual recovery cases. But this finding was worse than
the ONTT results; visual acuity was better than 20/20 in 74%
of patients, and 20/25 to 20/40 in 18% of patients after
10-year follow-up.3 In our study, among 12 affected eyes
with severe vision loss (< 20/1000) during the first episode
of ON, 9 eyes had recovered visual acuity better than
20/40. In the ONTT, it was suggested that baseline visual
acuity (worse than 20/200) was the best predictor for the
6-month visual acuity outcome.10 Patients of the poor
outcome group (visual acuity < 20/40) had more severe loss
of visual acuity at baseline, and more often had a recurrent
attack of ON within the first 6 months. However, they also
suggested the strength of this association is more statisti-
cally rather than clinically important, because most
patients with severe initial loss of vision still had good visual
recovery.10 In the study by Chang et al,12 the initial BCVA
had no positive or negative correlation with the final
BCVA.11 In our study, baseline visual acuity was not asso-
ciated with poor visual outcome (Table 1).
Both central vision and visual field improvement were
stable at 6-month follow-up and lasted longer in our study.
Bee et al13 found that visual acuity and color vision in the
unilateral group started to improve within the first 2 weeks
after treatment, and visual acuity was similar at 2 weeks
and 1 year. In the ONTT, visual recovery generally begins
within the first 2 weeks after the onset of visual symptoms.
Most improvement occurs by the end of the first month.
Patients with incomplete recovery at 6 months may
continue to improve slightly between 6 months and 1 year
of follow-up.10
The mean annual incidence of ON was not low (33/
100000), but the conversion rate of ON to MS was low in
a population-based study in Taiwan.14 This low conversion
rate was also noted in hospital-based studies in Taiwan
(Table 3). This result is different from that of the Western
population, in which the conversion rate to MS is high,ranging from 38% to 75% with varied length of follow-up.1
According to several studies, MRI is the most significant
predictor of MS conversion.1,4,7 Other identified risk factors
included female sex, retrobulbar type of ON, elevated
cerebrospinal fluid-immunoglobulin G index, and recurrent
attacks.7 In the ONTT, male sex and optic disc swelling
were found to be associated with a lower risk of MS.4 In our
study, despite a higher percentage of retrobulbar ON, the
MS conversion rate was still low. Therefore, retrobulbar
type ON was probably not the main factor to explain the
difference in MS conversion rate.
Another feature of MS in the Asian population is the
selective and severe involvement of the optic nerve and
spinal cord (OS-MS).5In the study by Lin et al,7 approxi-
mately half of their patients with MS had abnormal MRI
lesions in the spine instead of in the brain. Chang et al15
also reported that 56% of the MS in Taiwanese patients
was OS-MS.15 In our study, MS was diagnosed in two
patients, and OS-MS in one patient. Recent studies have
proposed that the opticospinal form of MS may be identical
to NMO by a serum autoantibody marker of NMO (anti-
aquaporin-4 antibody).16
Summary
Our prospective study found recurrent ON to be statistically
significant in predicting the visual outcome and the overall
visual prognosis. Patients with recurrent ON had worse
visual outcome than patients with nonrecurrent ON. In
addition, only a low degree of association of ON with MS
was found in our study. The major limitation of this
preliminary study was its small sample size and short
follow-up time.References
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